AMINO-REACTIVE POSITIVELY CHARGED ATRP INITIATORS THAT MAINTAIN THEIR POSITIVE CHARGE DURING SYNTHESIS OF BIOMACRO-INITIATORS
Provided herein are materials and methods that include utilizing atom transfer radical polymerization (ATRP) initiator molecules that maintain a positive charge during biomacro-initiator synthesis.
This application claims priority from U.S. Provisional Application Ser. No. 62/764,395, filed Aug. 1, 2018, which is incorporated by reference herein in its entirety.
TECHNICAL FIELDThis document relates to materials and methods that can facilitate atom transfer radical polymerization (ATRP) reactions, and more particularly to ATRP initiator molecules that maintain a positive charge during biomacro-initiator synthesis.
BACKGROUNDThe delicate balance of forces that maintain the structure, function and dynamics of enzymes is at the heart of their remarkable activity and bothersome instability (Taverna and Goldstein, Proteins 2002, 46(1):105-109). Although some enzymes have evolved to survive in extreme environments (Calligari et al., J. Phys. Chem. B 2015, 119(25):7860-7873), protein engineers that desire to stabilize proteins for therapeutic or industrial use have generally used molecular biology to dramatically improve function (de Champdoré et al., J. R. Soc. Interface 2007, 4(13):183-191; Coker, F1000Research 2016, 5; and Radestock and Gohlke, Eng. Life Sci. 2008, 8(5):507-522). Another compelling approach to protein/enzyme stabilization has used covalently attached polymers to impart stability. Polymers such as polyethylene glycol (PEG) can be covalently coupled to the surface of an enzyme (commonly referred to as PEGylation) or grown from the surface of proteins using controlled radical polymerization from protein-initiator complexes. Protein-initiator complexes are most often formed by reacting accessible surface amino groups with activated ester alkyl halides. These reactions, and almost all PEGylation coupling chemistries, sacrifice the native electrostatic environment of the protein surface for the supposed benefit of the resulting conjugate.
The prevailing view of protein scientists has been that maintaining protein surface charge-charge interactions is less important to protein stability that maintaining the integrity of the hydrophobic core. Indeed, the hydrophobic interactions within a protein contribute hundreds of kJ mol−1 to maintaining a folded conformation, whereas exposed surface charge-charge interactions only contribute a few kJ mol−1 (Pace et al., FEBS Lett. 2014, 588(14):2177-2184; Dill, Biochemistry 1990, 29(31):7133-7155; Zhang et al., Phys. Biol. 2011, 8(3):35001; and Pace et al., FASEB J. 1996, 10(1):75-83). Surprisingly, however, rationally optimizing charge-charge interactions, both experimentally and computationally as a predictive tool, is still an effective strategy in designing proteins with high stability (Park et al., Curr. Opin. Struct. Biol. 2004, 14(4):487-494; Dwyer et al., Science 2004, 304(5679):1967-1971; and Lee et al., Biochemistry 2005, 44:16817-16825). It also has been observed that long-range electrostatic interactions are as important as short-range salt bridge interactions (Lee et al., supra). Additionally, charge-charge interactions can either be optimized by increasing favorable electrostatic interactions or by decreasing the number of unfavorable electrostatic interactions (Koide et al., Biochemistry 40:10326-10333). Conversely, others have questioned whether charge-charge interactions are important influencers of stability (Loladze and Makhatadze, Protein Sci. 2002, 11(1):174-177; Hollecker and Creighton, Biochim. Biophys. Acta—Protein Struct. Mol. Enzymol. 1982, 701(3):395-404; Xiao et al., Proc. Natl. Acad. Sci. USA 2013, 110(28):11337-11342; Ugarova et al., Biochim. Biophys. Acta—Enzymol. 1979, 570(1):31-42; and Perutz, Science 1978, 201(4362):1187-1191). It is not surprising, therefore, that the protein-polymer conjugate community has all but ignored the impact of polymer attachment chemistry on surface charge.
Protein modification is not only used to increase protein robustness, but also to diversify functionality and modulate activity (Radestock and Gohlke, supra; Pokala and Handel, J. Struct. Biol. 2001, 134(2-3):269-281; Shoichet et al., Proc. Natl. Acad. Sci. USA 1995, 92(2):452-456; and Thilakarathne et al., Langmuir 2011, 27(12):7663-7671). The human body does this naturally through post-translational modification (e.g., by glycosylation, phosphorylation, lipidation, and/or nitrosylation). For example, glycosylation introduces sugar moieties to the surfaces of proteins which alters protein folding, stability, solubility, and dynamics (Shental-Bechor and Levy, Proc. Natl. Acad. Sci. USA 2008, 105(24):8256-8261; Sold and Griebenow, BioDrugs 2010, 24(1); 9-21; Welinder et al., Prog. Biotechnol. 1995, 10:205-210; and Lee et al., Sci. Rep. 2015, 5:892).
Over the past four decades, scientists have engineered proteins with covalently attached synthetic polymers for a variety of therapeutic and industrial applications (Cummings et al., ACS Macro Lett. 2016, 5(4):493-497; Murata et al., Biomacromolecules 2013, 14(6):1919-1926; Veronese et al., Drug Discov. Today 2005, 10(21):1451-1458; Cummings et al., Biomacromolecules 2017, 18(2):576-586; Parrott et al., Nat. Chem. 2011, 4(1):13-14; Lozano et al., Biotechnol. Bioeng. 2001, 75(5):563-569; Huang et al., ACS Appl. Mater. Interfaces 2015, 7(27):14660-14669; Campbell et al., Electrochim. Acta 2017, 248:578-584; and Shakya and Nandakumar, J. Roy. Soc. Interface 2018, 15(139):1-15). Of the twelve FDA-approved therapeutic protein-polymer conjugates, only one maintained surface charge during PEG attachment (Pelegri-Oday et al., J. Am. Chem. Soc. 2014, 136(41):14323-14332). In grafting-from protein-polymer conjugate synthesis, where initiators are first attached to targeted sites on the protein surface from which controlled radical polymerization occurs, surface charge has also been ignored (Lele et al., Biomacromolecules 2005, 6(6):3380-3387; Kovaliov et al., Polymer (Guildf). 2018, 137:338-345; and Paeth et al., Methods Enzymol. 2017, 590:193-224). ATRP has been used to grow dense polymer coatings that “nano-armor” proteins (Matyjaszewski and Tsarevsky, J. Am. Chem. Soc. 2014, 136(18):6513-6533; and Averick et al., ACS Macro Lett. 2012, 1(1):6-10). A wide variety of polymers with a broad range of molecular weights and densities have been conjugated with proteins to determine their impact on function, including random copolymers (Panganiban et al., Science 2018, 359(6381):1239-1243), block copolymers (Kulkarni et al., Biomacromolecules 2006, 7(10):2736-2741; Huang et al., supra; and Cummings et al., Biomacromolecules 2014, 15(3):763-771), thermoresponsive polymers (Murata et al., supra; Huang et al., supra; and Trzebicka et al., Prog. Polym. Sci. 2017, 68:35-76), pH-responsive polymers (Cummings et al., Biomaterials 2013, 34(30):7437-7443), branched polymers (Gauthier and Klok, Polym. Chem. 2010, 1(9):1352), and charged polymers (Cummings 2017, supra; Lucius et al., Biomacromolecules 2016, 17(3):1123-1134; and Bhattacharjee et al., ChemBioChem 2015, 16(17):2451-2455). The charge of the ATRP-initiator has never been explored.
SUMMARYRational design of protein-polymer conjugates by protein-ATRP has remained elusive because the polymers can have unpredictable effects on the activity and stability of the formed bioconjugates. For the most part, the assumption has been that the physicochemical properties of the polymer dominate the resulting bioactivity and stability. Molecular dynamics simulations have shown, however, that the polymer rarely interacts intimately. Attention therefore has focused on the interface between the polymer and the protein and, in particular, on maintaining the electrostatic environment at the surface of enzymes during the growth of polymers.
This document is based on the development of a novel, amino-reactive, positively charged ATRP initiator that maintains its permanent positive charge during the synthesis of biomacro-initiators. Enzymatic macro-initiators generated as described herein maintained surface charge and suffered none of the deleterious effects on activity and stability exhibited by their counterparts generated with a neutral initiator. Further, this document is based, at least in part, on the discovery that maintaining the electrostatic environment during initiation can protect enzyme activity during and after the growth of protein-compatible polymers, as well as polymers that typically inactivate proteins. Embodiments include the positively charged N-hydroxysuccinimidyl ester protein-ATRP-initiator that was synthesized as described herein, as well as methods for using such initiators in the design and synthesis of functional protein-polymer conjugate variants.
In a first aspect, this document features a method for generating a protein-initiator conjugate, comprising contacting a protein with an ATRP initiator, where the ATRP initiator includes an amine-reactive group, one or more alkyl halide groups, and a positively charged group. The amine-reactive group can include an active ester (e.g., an N-hydroxysuccinimide ester, a nitrophenol ester, a pentafluorophenol ester, or an oxybenzotriaole ester). The alkyl halide can include bromine or chlorine. The positively charged group can include a quaternary ammonium. The protein can be an enzyme (e.g., an esterase, a lipase, an organophosphate hydrolase, an aminase, an oxidoreductase, a hydrogenase, or lysozyme).
In another aspect, this document features a protein-initiator conjugate containing a protein coupled to an ATRP initiator, where the ATRP initiator includes an amine-reactive group, one or more alkyl halide groups, and a positively charged group. The amine-reactive group can include an active ester (e.g., an N-hydroxysuccinimide ester, a nitrophenol ester, a pentafluorophenol ester, or an oxybenzotriaole ester). The alkyl halide can include bromine or chlorine. The positively charged group can include a quaternary ammonium. The protein can be an enzyme (e.g., an esterase, a lipase, an organophosphate hydrolase, an aminase, an oxidoreductase, a hydrogenase, or lysozyme).
In another aspect, this document features a method for generating a protein-polymer conjugate. The method can include contacting a protein-initiator conjugate with a population of monomers in the presence of a transition metal catalyst or metal-free organic complex that can participate in a redox reaction, where the initiator includes an amine-reactive group, one or more alkyl halide groups, and a positively charged group. The amine-reactive group can include an active ester (e.g., an N-hydroxysuccinimide ester, a nitrophenol ester, a pentafluorophenol ester, or an oxybenzotriaole ester). The alkyl halide can include bromine or chlorine. The positively charged group can include a quaternary ammonium. The protein can be an enzyme (e.g., an esterase, a lipase, an organophosphate hydrolase, an aminase, an oxidoreductase, a hydrogenase, or lysozyme). The monomer can be selected from the group consisting of carboxybetaine methacrylate, (oligo(ethylene glycol) methacrylate), 2-dimethylaminoethyl methacrylate, sulfobetaine methacrylate, 2-(methylsulfinyl)ethyl acrylate, oligo(ethylene oxide) methyl ether methacrylate, and (hydroxyethyl)methacrylate.
Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention pertains. Although methods and materials similar or equivalent to those described herein can be used to practice the invention, suitable methods and materials are described below. All publications, patent applications, patents, and other references mentioned herein are incorporated by reference in their entirety. In case of conflict, the present specification, including definitions, will control. In addition, the materials, methods, and examples are illustrative only and not intended to be limiting.
The details of one or more embodiments of the invention are set forth in the accompanying drawings and the description below. Other features, objects, and advantages of the invention will be apparent from the description and drawings, and from the claims.
ATRP is a type of a reversible-deactivation radical polymerization, and is a means of forming a carbon-carbon bond with a transition metal catalyst. ATRP typically employs an alkyl halide (R—X) initiator and a transition metal complex (e.g., a complex of Cu, Fe, Ru, Ni, or Os) as a catalyst. In an ATRP reaction, the dormant species is activated by the transition metal complex to generate radicals via electron transfer. Simultaneously, the transition metal is oxidized to a higher oxidation state. This reversible process rapidly establishes an equilibrium that predominately is shifted to the side with very low radical concentrations. The number of polymer chains is determined by the number of initiators, and each growing chain has the same probability of propagating with monomers to form living/dormant polymer chains (R—Pn—X). As a result, polymers with similar molecular weights and narrow molecular weight distribution can be prepared.
The basic ATRP process and a number of improvements are described elsewhere. See, for example, U.S. Pat. Nos. 5,763,546; 5,807,937; 5,789,487; 5,945,491; 6,111,022; 6,121,371; 6,124,411; 6,162,882; 6,624,262; 6,407,187; 6,512,060; 6,538,091; 6,541,580; 6,624,262; 6,627,314; 6,759,491; 6,790,919; 6,887,962; 7,019,082; 7,049,373; 7,064,166; 7,125,938; 7,157,530; 7,332,550; 7,407,995; 7,572,874; 7,678,869; 7,795,355; 7,825,199; 7,893,173; 7,893,174; 8,252,880; 8,273,823; 8,349,410; 8,367,051; 8,404,788; 8,445,610; 8,816,001; 8,865,795; 8,871,831; 8,962,764; 9,243,274; 9,410,020; 9,447,042; 9,533,297; and 9,644,042; and Publication Nos. 2014/0183055; 2014/0275420; and 2015/0087795.
ATRP also is discussed in a number of publications and reviewed in several book chapters. See, e.g., Matyjaszewski and Zia, Chem. Rev. 2001, 101:2921-2990; Qiu et al., Prog. Polym. Sci. 2001, 26:2083-2134; Wang and Matyjaszewski, J. Am. Chem. Soc. 1995, 117:5614-5615; Coessens et al., Prog. Polym. Sci. 2001, 26:337-377; Braunecker and Matyjaszewski, Prog. Polym. Sci. 2007, 32:93-146; Matyjaszewski, Macromol. 2012, 45:4015-4039; Schroder et al., ACS Macro Letters 2012, 1:1037-1040; Matyjaszewski and Tsarevsky, J. Am. Chem. Soc. 2014, 136:6513-6533; and Kamigaito et al., Chem Rev 2001, 101:3689-3746. Indeed, ATRP can control polymer composition, topology, and position of functionalities within a copolymer (Coessens et al., supra; Advances in Polymer Science; Springer Berlin/Heidelberg: 2002, Vol. 159; Gao and Matyjaszewski, Prog. Polym. Sci. 2009, 34:317-350; Blencowe et al., Polymer 2009, 50:5-32; Matyjaszewski, Science 2011, 333:1104-1105; and Polymer Science: A Comprehensive Reference, Matyjaszewski and Martin, Eds., Elsevier: Amsterdam, 2012; pp 377-428). All of the above-mentioned patents, patent application publications, and non-patent references are incorporated herein by reference to provide background and definitions for the present disclosure.
Monomers and initiators having a variety of functional groups (e.g., allyl, amino, epoxy, hydroxy, and vinyl groups) can be used in ATRP. ATRP has been used to polymerize a wide range of commercially available monomers, including various styrenes, (meth)acrylates, (meth)acrylamides, N-vinylpyrrolidone, acrylonitrile, and vinyl acetate as well as vinyl chloride (Qiu and Matyjaszewski, Macromol. 1997, 30:5643-5648; Matyjaszewski et al, J. Am. Chem. Soc. 1997, 119:674-680; Teodorescu and Matyjaszewski, Macromol. 1999, 32:4826-4831; Debuigne et al., Macromol. 2005, 38:9488-9496; Lu et al., Polymer 2007, 48:2835-2842; Wever et al., Macromol. 2012, 45:4040-4045; and Fantin et al., J. Am. Chem. Soc. 2016, 138:7216-7219). Non-limiting examples of monomers that can be used in ATRP reactions include carboxybetaine methacrylate (CBMA), oligo(ethylene glycol) methacrylate (OEGMA), 2-dimethylaminoethyl methacrylate (DMAEMA), sulfobetaine methacrylate (SBMA), 2-(methylsulfinyl)ethyl acrylate (MSEA), oligo(ethylene oxide) methyl ether methacrylate (OEOMA), and (hydroxyethyl)methacrylate (HEMA).
ATRP can be used to add polymer chains to the surfaces of proteins. An initial step in a protein-ATRP reaction is the addition of initiator molecules to the protein surface. In some cases, ATRP initiators (1) contain an alkyl halide as the point of initiation, (2) are water soluble, and (3) contain a protein-reactive “handle.” Alkyl halide ATRP-initiators usually include NHS groups that react with protein primary amines, including the N-terminal and lysine residues. Targeting amino groups can be the best way to achieve the highest polymer coating due to the high abundance of amino groups on protein surfaces. The initiation reaction can be somewhat controlled using carefully designed algorithms that can predict specific reaction rates and sites of the individual amino groups (Carmali et al., ACS Biomater. Sci. Eng. 2017, 3(9):2086-2097).
The amino group at the N-terminus typically has a pKa in the range of 7.8-8.0, while the pKa's of lysine side chains range from about 10.5 to 12.0, depending on their local environment (Murata et al., Nat. Commun. 2018, 9, 845). Therefore, at biologically relevant pH values (6-8), the accessible amino groups are positively charged. During ATRP reactions, these positive charges are lost upon initiator attachment, as most (if not all) initiators typically used in ATRP reactions are neutral (see, e.g., Le Droumaguet and Nicolas, Polym. Chem. 2010, 1(5):563; and Broyer et al., Chem. Commun. 2011, 47(8):2212).
As described herein, the positive charge on a protein surface can be maintained during and after the addition of polymer chains when a positively charged initiator is used. As further described herein, maintaining a positive charge on the protein can permit the protein to maintain its function after polymerization is complete—an important development for therapeutic and industrial protein-polymer conjugates. Thus, this document provides materials and methods for generating protein-polymer conjugates through ATRP while maintaining protein charge and function. In some aspects, for example, this document provides methods for polymer-based engineering of proteins such as the serine protease chymotrypsin, which can be used as a charged initiator on design of enzyme structure, dynamics and function by controlling the kinetics and stability of the chymotrypsin-initiator complexes. As described herein, neutral and positively charged initiators were used to grow poly CBMA (pCMBA) or poly SMA (pSMA) from the surface of various enzymes (
Also described herein are positively charged ATRP-initiators and methods for their synthesis. The positively charged ATRP-initiators can restore the native net charge on an enzyme surface, thereby enhancing activity and stability of the enzyme-initiator complex, as well as the protein-polymer conjugates derived from the enzyme-initiator complex. This document presents the first positively charged ATRP-initiator and demonstrates its impact on the activity and stability of protein-initiator complexes and protein polymer conjugates of enzymes such as α-chymotrypsin (CT), urease, acetylcholinesterase AChE), lysozyme, and avidin. Also described herein are methods for using the positive charge of an ATRP-initiator in the design of highly active and stable protein-polymer conjugate variants.
Any appropriate ATRP initiator can be used in the methods provided herein. Suitable initiators can be based on, for example, 2-bromopropanitrile (BPN), ethyl 2-bromoisobutyrate (BriB), ethyl 2-bromopropionate (EBrP), methyl 2-bromopropionate (MBrP), 1-phenyl ethylbromide (1-PEBr), tosyl chloride (TsCl), 1-cyano-1-methylethyldiethyldithiocarbamte (MANDC), 2-(N,N-diethyldithiocarbamyl)-isobutyric acid ethyl ester (EMADC), dimethyl 2,6-dibromoheptanedioate (DMDBHD), 2-chloro-2-methypropyl ester (CME), 2-chloropropanitrile (CPN), ethyl 2-chloroisobutyrate (CliB), ethyl 2-chloropropionate (EC1P), methyl 2-chloropropionate (MC1P), dimethyl 2,6-dichloroheptanedioate (DMDC1HD), or 1-phenyl ethylchloride (1-PEC1), provided that the initiator includes a group with a positive charge (in addition to an amine-reactive group and an alkyl halide or other group that can react with a monomer to initiate polymer addition to the protein). As described in the Examples below, for example, neutral initiator molecules such as those listed above can be modified by reaction with N-(3-N′,N′-dimethylaminopropyl)-2-bromo-2-methylpropanamide in the presence of acetonitrile (
In some embodiments, this document provides protein-initiator conjugates in which a protein is coupled to a controlled radical polymerization (CRP) (e.g., ARTP) initiator having an amine-reactive group, one or more alkyl halide groups, and a positively charged group. The amine-reactive group can react with amine groups on a protein surface, while the alkyl halide can react with a monomer to initiate polymerization. Any suitable amine-reactive group can be used. Examples of appropriate amine-reactive groups include active esters (e.g., N-hydroxysuccinimide ester, nitrophenol ester, pentafluorophenol ester, can oxybenzotriaole ester). Further, any suitable alkyl halide can be used. In some cases, the alkyl halide can include a bromine or a chlorine atom. Moreover, any suitable group can provide the positive charge to an initiator used in the methods provided herein. In some cases, for example, the positively charged group can include a quaternary ammonium.
Also provided herein are methods for generating protein-initiator conjugates, where the methods include contacting a protein with a positively charged CRP initiator. The initiator include can have an amine-reactive group for reaction with amine groups on a protein surface, and an alkyl halide group for reaction with a monomer to initiate polymerization. Again, any suitable amine-reactive group, any suitable alkyl halide, and any suitable positively charged group can be used, including those listed herein.
In some cases, the methods provided herein can further include using ATRP to generate a protein-polymer conjugate from a protein-initiator conjugate prepared as described herein. For example, a protein-initiator conjugate can be contacted with a population of monomers in the presence of a transition metal catalyst or metal-free organic complex that can participate in a redox reaction.
ATRP can be carried out using standard methods. For example, a protein-initiator/protein-blocker complex can be contacted with a population of monomers and a transition metal catalyst that includes a metal ligand complex. Any appropriate metal ligand complex can be used. The transition metal in the metal ligand complex can be, for example, copper, iron, cobalt, zinc, ruthenium, palladium, or silver. The ligand in the metal ligand complex can be, without limitation, an amine-based ligand (e.g., 2,2′-bipyridine (bpy), 4,4′-di(5-nonyl)-2,2′-bipyridine (dNbpy), N,N,N′,N′-tetramethylethylenediamine (TMEDA), N-propyl(2-pyridyl)methanimine (NPrPMI), 2,2′:6′,2″-terpyridine (tpy), 4,4′,4″-tris(5-nonyl)-2,2′:6′,2″-terpyridine (tNtpy), N,N,N′,N″,N″-pentamethyldiethylenetriamine (PMDETA), N,N-bis(2-pyridylmethyl)octylamine (BPMOA), 1,1,4,7,10,10-hexamethyltriethylenetetramine (HMTETA), tris[2-(dimethylamino)ethyl]amine (Me6TREN), tris[(2-pyridyl)methyl]amine (TPMA), 1,4,8,11-tetraaza-1,4,8,11-tetramethylcyclotetradecane (Me4CYCLAM), or N,N,N′,N′-tetrakis(2-pyridylmethyl)ethylenediamine (TPEN). The invention will be further described in the following examples, which do not limit the scope of the invention described in the claims.
EXAMPLES Example 1—Materials and MethodsMaterials: α-chymotrypsin (CT) from bovine pancreas (type II), acetylcholinesterase (AChE) from Electrophorus electricus (electric eel, type Vl-S), Uricase from Candida sp., and Lysozyme 548 from chicken egg white were purchased from Sigma Aldrich (St. Louis, Mo.). CT and Lysozyme were used as received. AChE and Uricase were dialyzed in 25 mM sodium phosphate (pH 7.0) using a 25 kDa molecular weight cutoff dialysis tube in a refrigerator for 24 hours and then lyophilized. Copper (II) chloride, sodium ascorbate, 1,1,4,7,10,10-hexamethyltriethylenetetramine (HMTETA), 2-bromo-2-methylpropionyl bromide, 3-(dimethylamino)-1-propylamine, N,N′-diisopropylcarbodimine, fluorescamine, acetylthiocholine iodide, 5,5′-dithiobis(2-nitrobenzoic acid) (DTNB) were purchased from Sigma Aldrich. 4-bromobutyric acid and N-hydroxysuccinimide were purchased from TCI USA (Portland, Oreg.). Micro BCA assay kit was purchased from Thermo Fisher Scientific.
Instrumentation and Sample Analysis Preparations: 1H and 13C NMR were recorded on a spectrometer (500 MHz, 125 MHz, Bruker Avance™ 500) with deuterium oxide (D2O) and DMSO-d6. Routine FT-IR spectra were obtained with a Nicolet Avatar 560 FT-IR spectrometer (Thermo). UV-VIS spectra were obtained and used for enzyme activity determination using an UV-VIS spectrometer (Lambda 45, PerkinElmer) with a temperature-controlled cell holder. Melting points (mp) were measured with a Laboratory Devices Mel-Temp. Number and weight average molecular weights (Mn and Mw) and the polydispersity index (Mw/Mn) were estimated by gel permeation chromatography (GPC) on a Water 2695 Series with a data processor, equipped with three columns (Waters Ultrahydrogel Linier, 500 and 250), using Dulbecco's Phosphate Buffered Saline with 0.02 wt % sodium azide for pCBMA and 80 vol % of 100 mM sodium phosphate (pH 9.0) and 20 vol % of acetonitrile for pSMA as an eluent at flow rate 1.0 mL/min, with detection by a refractive index (RI) detector. Pullulan standards (PSS—Polymer Standards Service—USA Inc, Amherst, Mass.) were used for calibration. Matrix-Assisted Laser Desorption Ionization Time-of-Flight Spectrometry (MALDI-TOF MS) was performed with a Perseptive Biosystems Voyager Elite MALDI-TOF spectrometer. Dynamic Light Scattering (DLS) data were collected on a Malvern Zetasizer nano-ZS. The concentration of the sample solution was kept at 0.2-1.0 mg/mL. The hydrodynamic diameter of samples was measured three times (15 run to each measurement) in various buffers.
Positive Initiator (1) Synthesis and Characterization
4-bromobutyloyl-N-oxysuccinimide ester (2): N,N′-diisopropylcarbodimine (8.5 mL, 55 mmol) was slowly added to the solution of 4-bromobutyric acid (8.4 g, 50 mmol) and N-hydroxysuccinimide (4.3 g, 55 mmol) in dichloromethane (100 mL) at 0° C., and the mixture was stirred at room temperature overnight. Precipitated urea was filtered out and the filtrate was evaporated to remove solvent. 4-bromobutyloyl-N-oxysuccinimine ester was isolated by recrystallization in 2-propanol; yield 589 10.2 g (77%), mp 49-52° C. 1H NMR (500 MHz, DMSO-d6) δ 2.16 (m, 2H, C═OCH2CH2CH2Br), 2.81 (s, 4H, succinimide), 2.83 (t, 2H, J=7.0 Hz, C═OCH2CH2CH2Br), 3.60 (t, 2H, J=7.0 Hz, C═OCH2CH2CH2Br) ppm; 13C NMR (125 MHz, DMSO-d6) δ 25.9, 27.9, 29.5, 33.3, 168.7, 170.6 ppm; IR (KBr pellete) 3017, 2948, 2914, 2852, 1812, 1786, 1731, 1382, 1360, 1311, 1202 and 1150 cm−1.
N-(3-N′,N′-dimethylaminopropyl)-2-bromo-2-methylpropanamide (3): 2-bromo-2-methylpropionyl bromide (3.4 mL, 27 mmol) was slowly added into the solution of 3-(dimethylamino)-1-propylamine (3.1 mL, 24.6 mmol) in deionized water (50 mL) at 0° C., and the the mixture was stirred at room temperature for 1 hour. After the mixture adjusted to pH 10 with 5 N NaOH aq. at 0° C., the product was extracted with ethyl acetate (50 mL×3). The organic phase was washed with 20 wt % of potassium carbonate aq. (50 mL×3) and saturated NaCl aq. (50 mL×2). The organic phase was dried with Na2CO3 and evaporated to remove solvent. N-(3-N′,N′-dimethylaminopropyl)-2-bromo-2-methylpropanamide was obtained in vacuum. oil compound; yield 5.9 g (95%), 1H NMR (500 MHz, DMSO-d6) δ 1.56 (m, 2H, (CH3)2NCH2CH2CH2NHC═O), 1.84 (s, 6H, C═OC(CH3)2Br), 2.11 (s, 6H, (CH3)2NCH2CH2), 2.22 (t, 2H, J=7.0 Hz, (CH3)2NCH2CH2), 3.12 (td, 2H, J=5.5 Hz and J=7.0 Hz, CH2CH2NHC═O), 8.20 (broad t, 1H, J=5.5 Hz, amide) ppm; 13C NMR (125 MHz, DMSO-d6) δ 26.7, 31.6, 38.7, 45.5, 57.4, 61.5, 170.9 ppm; IR (NaCl plate) 3349, 2975, 2946, 2864, 2822, 2800, 1661, 1537, 1465, 1370, 1294, 1263, 1195, 1161 and 1113 cm−1.
Positively charged ATRP initiator (1): N-(3-N′,N′-dimethylaminopropyl)-2-bromo-2-methylpropanamide (1.9 g, 7.5 mmol) and 4-bromobutyloyl-N-oxysuccinimide ester (2.0 g, 1.5 mmol) were added in dried acetonitrile (50 mL) and bubbled with nitrogen gas for 10 minutes. The mixture was sealed and stirred at 40° C. overnight. Positively charged ATRP initiator (1) was precipitated in mixture of ethyl acetate and diethyl ether (1:1 volume ratio), and the oil compound was isolated in vacuo; yield 3.6 g (93%), 1H NMR (500 MHz, D2O) δ 1.88 (s, 6H, C═OC(CH3)2Br), 1.91-2.24 (m, 4H, C═OCH2CH2CH2N+CH2CH2CH2NHC═O), 2.83-2.93 (m, 9H, succinimide and C═OCH2CH2CH2N+(CH3)), 3.04-3.14 (m, 5H, C═OCH2CH2CH2N+(CH3)), 3.28-3.41 (m, 4H, N+CH2CH2CH2NHC═O) ppm; 13C NMR (125 MHz, D2O) 822.1, 24.0, 25.6, 30.6, 36.6, 42.9, 51.1, 55.4, 61.6, 62.1, 169.1, 173.2, 174.9 ppm; IR (NaCl plate) 3418, 2969, 2708, 1813, 1780, 1734, 1653, 1536, 1472, 1371, 1298, 1210, 1113 and 1074 cm−1.
Protein-Initiator Synthesis and Characterization
CT: 200 μL of NHS-functionalized ATRP initiator solution in DMSO (168 μmol, 56 mg for neutral and 87 mg for positive initiator, respectively) was added to CT solution (60 mg in 30 mL of 100 mM phosphate (pH 8.0)) and stirred at 4° C. for 2 hours. CT-initiator conjugates were dialyzed in deionized water using a 15 kDa molecular cutoff dialysis tube in a refrigerator for 24 hours and then lyophilized.
Lysozyme: 200 μL of NHS-functionalized ATRP initiator solution in DMSO (172 58 mg for neutral and 89 mg for positive initiator, respectively) was added to lysozyme solution (70 mg in 30 mL of 100 mM phosphate (pH 8.0)) and stirred at room temperature for 2 hours. Lysozyme-initiator conjugates were dialyzed in deionized water using an 8 kDa molecular cutoff dialysis 632 tube in a refrigerator for 24 hours and then lyophilized.
Uricase: 200 μL of NHS-functionalized ATRP initiator solution in DMSO (100 μmol, 34 mg for neutral and 52 mg for positive initiator, respectively) was added to Uricase solution (20 mg of 638 Uricase in 20 mL of 100 mM phosphate (pH 7.0)) and stirred at room temperature for 2 hours. Uricase-initiator conjugates were dialyzed in 25 mM sodium phosphate (pH 7.0) using a 25 kDa molecular cutoff dialysis tube in a refrigerator for 24 hours and then lyophilized. The concentration of Uricase initiator conjugates was determined using a Micro BCA Assay Kit (ThermoFisher Scientific).
AChE: 100 μL of NHS-functionalized ATRP initiator solution in DMSO (12.7 μmol, 4.3 mg for neutral and 5.5 mg for positive initiator, respectively) was added to AChE solution (7 mg of AChE in 10 mL of 100 mM phosphate (pH 8.0)) and stirred at room temperature for 2 hours. AChE-initiator conjugates were dialyzed in 25 mM sodium phosphate (pH 7.0) using a 25 kDa molecular cutoff dialysis tube in a refrigerator for 24 hours and then lyophilized. The concentration of AChE initiator conjugates was determined using a Micro BCA Assay Kit.
BCA protein assay: The concentration of protein in the solution was determined using a Micro BCA protein Assay Kit (ThermoFisher Scientific). The sample solution (25 μL) and Micro BCA working reagent (75 μL) were incubated at 60° C. for 1 hour. After 900 μL of deionized water was added, the absorbance at 562 nm was recorded by a UV-VIS spectrometer (Lambda 45, Perkin Elmer). The standard curve was obtained from native protein with different concentration.
Fluorescamine assay: A fluorescamine assay was used to determine the number of initiators bound on the protein surface. 40 μL of sample, 100 mM sodium phosphate (40 μL, pH 8), and fluorescamine solution in DMSO (20 μL, 3 mg/mL) were added to wells of a 96-well plate and incubated at room temperature for 15 minutes. Fluorescence intensities were measured at the excitation of 390 nm and emission of 470 nm with 10-nm bandwidths by a Safire Spike plate reader. Concentrations were determined using a standard curve obtained from the native protein.
Trypsin digestion of protein-initiators: Trypsin digestion was performed on protein-initiators to generate peptide fragments to determine modification sites. Peptide fragments were analyzed using matrix-assisted laser desorption/ionization time-of-flight (MALDI-ToF) mass spectrometry. Native CT, CT-neutral initiator, and CT-positive initiator were digested according to the protocol described in the In-Solution Tryptic Digestion and Guanidination Kit. 20 μg of protein or protein-initiator complexes (10 of a 2 mg/mL protein solution in deionized water) were added to 15 μL of 50 mM ammonium bicarbonate with 1.5 μL of 100 mM dithiothreitol (DTT) in an Eppendorf tube. The reaction was incubated for 5 minutes at 95° C. Three (3) μL of 100 mM iodoacetamide aqueous solution was then added and samples were incubated in the dark for 20 minutes at room temperature for thiol alkylation. Next, 1 μL of 100 ng trypsin was added to the tube and the reaction was incubated at 37° C. for 3 hours. An additional 1 of 100 ng trypsin was subsequently added. The trypsin digestion was terminated after a total reaction time of 12 hours by the addition of trifluoroacetic acid (TFA). Digested samples were purified using ZipTipC18 microtips and eluted with 2 μL of matrix solution (20 mg/mL sinapinic acid in 50% acetonitrile with 0.1% TFA) directly onto a MALDI-ToF plate. The molecular weight of the expected peptide fragments before and after digestion was predicted using PeptideCutter on UniProt P00766 (ExPASy Bioinformatics Portal, Swiss Institute of Bioinformatics). CT-initiator digests were compared to native CT digests. Modification at a particular amino group was determined by either the loss of a peak of the CT-initiator in comparison to native CT or by the appearance of a new peak that equaled the mass (or adducts) of the peptide fragment plus the mass of the initiator (neutral initiator: 220 Da, positive initiator: 320 Da).
MALDI-ToF analysis: Protein solutions (1.0 mg/mL) were mixed with an equal volume of matrix (Sinapinic acid (20 mg/mL) in 50% acetonitrile with 0.4% trifluoroacetic acid), and 2 μL of the resulting mixture was loaded onto a silver sterling plate target. Apomyoglobin, cytochrome C, and aldolase were used as calibration standards. To determine the extent of initiator modification on protein-initiators, the m/z of the native protein was subtracted from the m/z of the protein-initiator. The difference in m/z was then divided by the mass of the initiator (neutral initiator: 220 Da, positive initiator: 320 Da) to obtain the number of initiators per protein. When analyzing trypsin digests of protein-initiators, Bradykinin fragment, angiotensin II (human) and insulin oxidized B chain (bovine) were used as calibration standards. MALDI-ToF data was collected on a PerSeptive Voyager STR MS with nitrogen laser (337 nm) and 20 kV accelerating voltage with a grid voltage of 90%. 300 laser shots covering the complete spot were accumulated for each spectrum.
Isoelectric Focusing (IEF) gel: Criterion IEF precast gels (pH 3-10, 12+2 well, polyacrylamide gel, 13.3×8.7 cm) from Bio-Rad were used to determine the isoelectric point of proteins and protein-initiators. Protein solutions (concentration depending on the sample) were mixed with 50% glycerol using a 1 to 10 ratio of protein sample to 50% glycerol. Thirty (30) μL were loaded into each well. The IEF standards were prepared and loaded according to the Bio-Rad instruction manual. The gel was run in a stepwise manner as follows: 100 V for 60 minutes, 250 V for 60 minutes, 500 V for 30 minutes. Gels were silver stained using the Pierce Silver Stain Kit following their instructions.
CT-pCBMA and pSMA conjugate synthesis: A solution of monomer (230 mg for CBMA and 246 mg for SMA, 1.0 mmol respectively) and CT-initiator (23 mg for neutral and 25 mg for positive initiator, 10 μmol of initiator) in 100 mM sodium phosphate (20 mL, pH 7) was sealed and bubbled with nitrogen gas in an ice bath for 30 minutes. Two (2) mL of deoxygenated catalyst solution (Cao et al., Nano Today 2012, 7(5):404-413) was the added to the polymerization reactor under bubbling nitrogen. The mixture was sealed and stirred in a refrigerator for 1 hour. The conjugate was isolated by dialysis with a 25 kDa molecular weight cutoff dialysis tube in deionized water in a refrigerator for 24 hours and then lyophilized. Conjugate CT content was determined by BCA assay as described elsewhere (Lee et al. 2005, supra). Other protein-polymer conjugates were prepared by the same procedure as CT-polymers.
Acid hydrolysis and characterization of cleaved polymer: The grafted polymer was cleaved by acidic hydrolysis from the conjugate. CT-polymer conjugate (20 mg) and 6 N HCl aq. (5 mL) were placed in a hydrolysis tube. After three freeze-pump-thaw cycles, the hydrolysis was performed at 110° C. for 24 hours in vacuum. The cleaved polymer was isolated by dialysis using a 1 kDa molecular weight cut off dialysis tube in deionized water and then lyophilized. The molecular weight of the cleaved polymer was measured by GPC.
Dynamic light scattering: Dynamic light scattering data was collected on a Malvern Zetasizer nano-ZS located in the Department of Chemistry, Carnegie Mellon University, Pittsburgh, Pa. The hydrodynamic diameters (number distribution) of samples were measured three times (5 runs for each measurement) at room temperature.
Prediction of log D ChemAxon was used to draw the structure of and calculate the hydrophobicity (log D) of lysine side chains and lysine-initiators.
Activity Assays
CT: N-succinyl-Ala-Ala-Pro-Phe-p-nitroanilide (Suc-AAPF-pNA; SEQ ID NO:1) was used as a substrate for CT. Substrate (0-20 mg/mL in DMSO, 30 μL) was added to a 1.5 mL cuvette with sodium phosphate buffer (pH 8, 100 mM). Native CT, CT-initiators, and CT-polymers (0.1 mg/mL protein, 4 μM, 10 μL) was added to the cuvette with substrate and buffer. The initial substrate hydrolysis rate was measured in triplicate by recording the increase in absorbance at 412 nm over the first 60 seconds after mixing using a Lambda 2 Perkin Elmer ultraviolet-visible spectrometer equipped with a temperature-controlled cell holder at 37° C. Michaelis-Menten parameters were determined using nonlinear curve fitting of initial hydrolysis rate versus substrate concentration in GraphPad.
Lysozyme: Activity of Native, Lysozyme-initiator and polymer conjugates was determined by turbidimetric assay. Lyophilized Micrococcus lysodeikticus (Sigma Aldrich) was used to monitor enzymatic catalysis of cell wall lysis. Absorption at 450 nm of suspended M. lysodeikticus (990 μL, 0.2 mg/mL) in 50 mM sodium phosphate (pH 6.0) was measured by UV-VIS spectrometer. 10 μL of native and Lysozyme-initiator solution (1.4 μM in 50 mM sodium phosphate (pH 6.0)) was added and the change of absorbance at 450 nm at room temperature was monitored.
Uricase: Uric acid (0-400 μL of 300 μM in in 50 mM sodium tetraborate (pH 8.5)) was mixed with 50 mM sodium phosphate (990-580 μL, pH 8.5). Native, initiator and polymer conjugate solution (10 μL, 20 μM of Uricase) was added to the substrate solution. The initial rate was monitored by recording the decreasing in absorbance as 290 nm using an UV-VIS absorbance spectrometer with a temperature controlled cell folder at 37° C. Michaelis-Menten parameters were determined by nonlinear curve fitting of initial rate versus substrate concentration plots using Prism 7 software (GraphPad).
AChE: Acetylthiocholine iodide (0-100 μL of 10 mM in 100 mM sodium phosphate buffer (pH 7.4)) and 10 μL of DTNB solution (50 mM in DMSO) was mixed with 100 mM sodium phosphate (980-880 μL, pH 7.4). Native, initiator and polymer conjugates solution (10 μL, 4.2 μM of AChE) was added to the substrate solution. The initial rate was monitored by recording the increasing in absorbance as 412 nm using an UV-VIS absorbance spectrometer with a temperature controlled cell folder at 37° C. Michaelis-Menten parameters were determined by nonlinear curve fitting of initial rate versus substrate concentration plots using Prism 7 software (GraphPad).
Residual Activity Assays
CT: Native CT, CT-initiators, and CT-polymers (1 mg/mL, 40 μM protein) were dissolved in sodium phosphate buffer (pH 8, 100 mM). In triplicate, samples were then diluted to 4 μM for incubation. For thermostability, samples were incubated at 50° C. and pH 8 in a circulating water bath. For acid stability, samples were incubated at pH 1 (167 mM HCl) and 37° C. At specified time points, aliquots of 10 μL were removed over 60 minutes and residual activity was measured using Suc-AAPF-pNA as a substrate (6 mg/mL, 30 μL, 288 μM in DMSO) in sodium phosphate buffer (pH 8, 100 mM, 37° C., 960 μL). Initial hydrolysis rate was measured as the increase in absorbance at 412 nm over 40 seconds and data was normalized to its optimal activity (pH 8, 37° C.) at time 0.
Lysozyme: Native lysozyme, initiator and polymer conjugates (14 μM of Lysozyme) in 50 mM sodium phosphate (pH 6.0) were incubated at 80° C. At given time, aliquots (10 μL) were removed and activity was measured in 990 μL of suspended M lysodeikticus (0.2 mg/mL) in 50 mM sodium phosphate (pH 6.0) at room temperature. Rates were monitored by recording the decreasing in absorbance at 450 nm using UV-VIS spectrometer. The residual activity was calculated as a ratio of initial rates of the reaction at the given incubation time over initial activity at time zero.
Uricase: Native uricase, initiator and polymer conjugates (20 μM of Uricase) in 50 mM sodium borate (pH 8.5) were incubated at 75° C. At given time, aliquots (10 μL) were removed and activity was measured in 990 μL of 100 μM of uric acid in 50 mM sodium borate (pH 8.5) at 37° C. Rates were monitored by recording the decreasing in absorbance at 290 nm using UV-VIS spectrometer. The residual activity was calculated as a ratio of initial rates of the reaction at the given incubation time over initial activity at time zero.
AChE: Native, initiator, and polymer conjugates (1.4 μM of AChE) in 100 mM sodium phosphate (pH 7.0) were incubated at 50° C. At given time, aliquots (10 μL) were removed and activity was measured in the mixture of 930 μL of 100 mM sodium phosphate (pH 7.4), 50 μL of acetylthiocholine iodide (10 mM in 100 mM sodium phosphate (pH 7.4) and 10 μL of DTNB solution (50 mM in DMSO) at 37° C. Rates were monitored by recording the increasing in absorbance at 412 nm using UV-VIS spectrometer. The residual activity was calculated as a ratio of initial rates of the reaction at the given incubation time over initial activity at time zero.
Tryptophan Fluorescence: Fluorescence measurements were collected using a BioTek Synergy H1 Plate Reader. Native CT, CT-initiators, and CT-polymers (1 mg/mL, 40 μM protein) were dissolved in sodium phosphate buffer (pH 8, 100 mM). Samples were diluted to 0.1 mg/mL (4 μM protein) in a black round bottom 96 well plate in triplicate. For thermostability, samples were incubated at 45° C. and pH 8. For acid stability, samples were incubated at pH 1 (167 mM HCl) and 37° C. Fluorescence intensity was measured every 2 minutes over 60 minutes (excitation at 270 nm, emissions at 330 nm and 350 nm). The ratio of emission fluorescence intensities (350 nm/330 nm) was plotted over time with time 0 as the fluorescence intensity of the sample at pH 8 and 37° C.
Molecular Dynamics Simulation: A CT-positive initiator model was built with the Maestro Schrodinger build toolkit using the crystal structure of CT as the initial structure (PDB: 4CHA). Positive initiators were attached to the N-terminus and all 14 lysine residues to create a fully modified CT-positive initiator complex. The molecule was subjected to a 1 ns simulated annealing using Desmond. Simulated annealing was performed in 4 stages: linear increasing temperature from 300-400 K over 0-100 ps, constant temperature at 400 K from 100-400 ps, linear decreasing temperature from 400-300 K over 400-700 ps, and constant temperature at 300 K from 700-1000 ps. The simulation system was prepared in Desmond system builder and consisted of OPLS 2005 force field, SPC water model, orthorhombic minimized box, and NaCl ions to neutralize the box followed by the addition of 100 mM NaCl. NVT ensemble and Berendsen thermostat were used to control temperature with a 1 ps relaxation time. The van der Waals interaction had a cutoff of 9 Å and particle mesh Ewald was used for Coulomb interactions with a 9 Å switching distance. The molecule was simulated using Desmond over 1 ns with a 1.2 ps recording energy interval and 5 ps trajectory recording. A molecular dynamics simulation production run was performed on the final structure from simulated annealing. The simulation was performed over 20 ns at 300 K with a NPT ensemble (trajectories were recorded every 1.2 ps and energy was recorded every 4.8 ps). The trajectory was then loaded into Visual Molecular Dynamics (VIVID) software for further analysis. The VIVID salt bridge plug-in was used to monitor salt bridge formation and location over the 20 ns trajectory.
Example 2—Protein-Initiators and Protein-Polymer ConjugatesA positively charged ATRP-initiator (
The initiator was used to grow pCBMA or pSMA from the chymotrypsin surface (
The CT-initiator complexes were analyzed with MALDI-ToF mass spectroscopy to determine the average number of amino groups that had been modified (
To obtain the data presented in TABLE 1, two conjugates were synthesized for each macroinitiator: one with pCBMA and one with pSMA. Degree of initiator modification was determined using MALDI-ToF mass spectroscopy. Protein-polymer conjugates were characterized by various methods. A bicinchoninic acid (BCA) assay was used to determine protein content from which total conjugate molecular weight and degree of polymerization were estimated. Polymers were cleaved from the protein surface using acid hydrolysis to be analyzed separately by gel permeation chromatography (GPC). The polymer molecular weight, and thus degree of polymerization, as well as total conjugate molecular weight were estimated. Hydrodynamic diameters (Dh) were also measured using dynamic light scattering and are reported as number distributions. All conjugates had similar degrees of polymerization around 100. Conjugates also grew in hydrodynamic diameter in comparison to native CT.
ATRP was used to synthesize CT-pCBMA and CT-pSMA conjugates from the neutral and positive protein-initiator complexes. The molecular weight of the polymers was kept constant (targeted degree of polymerization of 100) in order to compare the activity and stability of each conjugate to that of the native enzyme (Murata et al., Biomacromolecules 2014, 15(7):2817-2823). After ATRP and purification of the conjugate via dialysis, protein-polymer conjugates were characterized with a bicinchoninic acid (BCA) assay to determine protein concentration from which conjugate molecular weight and degree of polymerization were estimated (Lele et al., supra). The polymers also were cleaved from the protein surface via acid hydrolysis, and the isolated polymers were analyzed by gel permeation chromatography for relative molecular weight and polydispersity (PDI), from which conjugate molecular weight and degree of polymerization were estimated. The two characterization techniques agreed well, showing that the conjugates had similar degrees of polymerization. Hydrodynamic diameters (Dh) were also measured using dynamic light scattering and conjugates grew in size from 3.98 nm for native CT to approximately 18 nm for CT-pCBMA conjugates and approximately 13 nm for CT-pSMA conjugates grown from either CT-neutral or CT-positive initiators (TABLE 1).
Example 2—Activity of Chymotrypsin-Initiators and Chymotrypsin-Polymer ConjugatesMichaelis-Menten kinetics were measured at pH 8 and 37° C. using Succinyl-Ala-Ala-Pro-Phe-p-nitroanilide (Suc-AAPF-pNA; SEQ ID NO:1), a hydrophobic and negatively charged substrate for CT that binds to the hydrophobic S1 binding pocket and is then cleaved by the catalytic triad (Ser 195, His 57, Asp 102). The turnover numbers (kcat, s−1), Michaelis constants (KM, μM), and specificity constants (kcat/KM, μM−1s−1) were determined for the CT-neutral initiator, CT-positive initiator and the conjugates (TABLE 4). The CT-neutral initiator and CT-positive initiator had similar activities, but both had higher overall catalytic efficiencies than native CT due to a decrease in KM by half. The observed decrease in KM upon neutral initiator attachment could have been the result of the hydrophobicity of the initiator. The partition coefficient (log D) of a lysine side chain at pH 8.0 is −1.00. After covalent attachment of the neutral initiator, the log D value of the new product rose to 1.82. Considering that this reaction occurred on 14 out of the possible 15 amino groups, the surface of CT would undoubtedly have become more hydrophobic, which would have strengthened the van der Waals interactions between the hydrophobic substrate and hydrophobic S1 binding pocket to increase the affinity for the substrate. After attachment of the positive initiator, however, the log D decreased to −1.98, but the positive charge would have promoted favorable electrostatic interactions with the negatively charged substrate to increase the binding affinity.
Attachment of polymers to proteins can cause dramatic activity reductions, which has been attributed to protein structural stiffening (Rodriguez-Martinez et al., Biotechnol. Bioeng. 2008, 101(6):1142-1149). The turnover numbers for the CT-neutral initiator-pCBMA and CT-positive initiator-pCBMA were similar to that of the native CT, and the KM remained decreased. It was possible that pCBMA's super-hydrophilicity could pull water molecules away from the protein surface and into the polymer phase, which would strengthen the hydrophobic-hydrophobic driving force for substrate binding (Cao et al., supra). When using the positive initiator, CT-pCBMA had an increased kcat/KM (0.30±0.01 to 0.42±0.02 μM−1s−1), with an increased kcat and a decreased KM (TABLE 4). The overall catalytic efficiency of CT-positive initiator-pCBMA was nearly double that of native CT.
Zwitterionic polymers are known to stabilize proteins, whereas negatively charged polymers, such as pSMA, can inactivate CT rapidly. Indeed, tryptophan fluorescence intensity at pH 8 after synthesis of the CT-neutral initiator-pSMA conjugate was synthesized increased, indicating that the conjugate was already partially unfolded even in its most optimal environment. The growth of pSMA from CT-neutral initiator caused CT to lose 97% of its activity. A positively charged initiator might protect enzymes from polymer-induced decreases in function. Excitingly, the CT-positive initiator-pSMA conjugate had restored activity compared to native CT in terms of both kcat and KM and a nearly 20-fold higher overall activity than CT-neutral initiator-pSMA.
Replacing neutral NHS amino-reactive protein modifiers with positively charged modifiers also can impact protein stability. Various strategies have been used to stabilize CT including by adding excipients (polyols and salts) (Lozano et al., J. Biotechnol. 1994, 35(1):9-18; Levitsky et al., Eur. J. Biochem. 1994, 219(1-2):231-236; and Baldwin, Biophys. J. 1996, 71(4):2056-2063), immobilization onto solid supports (Mozhaev et al., Biotechnol. Bioeng. 1990, 35(7):653-659), encapsulation into reverse micelles (Dorovska-Taran et al., Eur. J Biochem. 1993, 211(1-2):47-55), or by covalent attachment of polymer (Cummings et al. 2017, supra).
CT has a two-step deactivation mechanism where it undergoes complete deactivation via an intermediate transition state as follows (1),
where F, I, and U are the folded, intermediate, and unfolded conformational states, and k1 and k2 are first order deactivation rate constants (min−1). CT resists inactivation by either not unfolding or refolding at a high rate (Lozano et al., Eur. J. Biochem. 1997, 248(1):80-85). The resistance of CT-initiator complexes and polymer conjugates to inactivation was determined using heat (50° C., pH 8) and acid (pH 1, 37° C.) (
To further explore whether net charge restoration caused the observed effects on stability, a CT-initiator complex was synthesized that contained a random mixture of neutral and positive initiators around the protein surface. Characterization by MALDI-ToF showed that the complexes contained an average of 9 neutral and 5 positive initiators per CT (
Further studies were conducted to determine the impact of initiator charge on enzyme-polymer conjugate stability. Residual activities of CT-pCBMA and CT-pSMA conjugates, grown from either neutral or positive initiators, were measured after incubation at either high temperature (
Other work has elucidated the mechanism of CT-polymer conjugate resistance to acid induced irreversible inactivation. In acid, the CT-positive initiator-pCBMA conjugate maintained about 60% residual activity, compared to about 40% for CT-neutral initiator-pCBMA. Remarkably, even the CT-positive initiator-pSMA conjugate had higher stability and was able to maintain 20% residual activity as compared to CT-neutral initiator-pSMA, which was immediately and irreversibly inactivated.
Example 4—Molecular Dynamics SimulationIn order to deepen the understanding of why positively charged initiator-CT complexes might restore native stability, a short (20 ns) all-atom molecular dynamics (MD) simulation was performed in a water box with periodic boundary conditions on a fully modified CT (PDB: 4cha) with positive initiators. The simulation was performed to mimic experimental conditions by adjusting the protonation states of ionizable groups to pH 8 and adding 100 mM NaCl. The system was subjected to a short (1 ns) simulated annealing to place the molecule in its lowest energy state and remove bias before starting the 20 ns production run. MD simulations were performed using the OPLS2005 force field and the average radius of gyration was 1.85 nm which was validated against experimental hydrodynamic diameter data (
A simple charged initiator might have a dramatic array of negative charges in the polymer. After all, the CT-pSMA conjugate retained 10 positive charges at its surface, but added over 1,000 positive charges to the molecular shell. Charged groups produce an electric field due to interactions with other charged particles in close proximity. The electric field strength at a surface with propagating point charges can be estimated using (equation 2),
where E is electric field (NC−1), k is Coulomb's constant (9.0E9 Nm2C−2), q is the signed magnitude of the point charge, and r is the distance between the charges. Therefore, the electric field strength is proportional to the magnitude of the electric charge and inversely proportional to the distance. A CT-positive initiator-pSMA conjugate of one polymer chain was modeled to estimate the electric field strength at the protein surface (
Although the positively charged initiator results with chymotrypsin were truly compelling, there was a possibility that the effect may have been enzyme-specific. The impact of the positively-charged initiator on the activity and stability of a widely divergent group of enzymes, enzyme-initiator complexes and enzyme-polymer conjugates was therefore explored. Lysozyme (14.3 kDa, 7 amines), avidin (16.4 kDa, 10 amines), uricase (35 kDa, 35 amines), and acetylcholinesterase (AChE, 70 kDa, 26 amines) have differing molecular weights, numbers of amino groups, active sites, and multimeric characteristics. The degree of initiator modification for each protein-initiator complex was determined using a fluorescamine assay, except for lysozyme samples, which were small enough to be determined by MALDI-ToF (
Lysozyme: Lysozyme (Lyz) is a small, single sub-unit protein that is an antimicrobial enzyme and is important for the immune system. Lysozyme hydrolyzes the β-1,4 glycosidic linkages between N-acetylmuramic acid and N-acetylglucosamine that are present in the cell wall of the bacteria. As seen for CT, the positive initiator modified fewer amino groups than the neutral initiator, but high degrees of modification were still achievable (TABLE 3). Lysozyme activity was measured by the change in absorbance at 450 nm over time when using Micrococcus lysodeikticus as a substrate. The lysozyme-neutral initiator complex was almost completely inactive (two orders of magnitude less activity than native lysozyme. The compelling results with CT were mirrored for the lysozyme-positive initiator complex, however, and complete restoration of activity for the complex was observed. Growth of pCBMA from Lyz-neutral initiator complex regained activity lost upon neutral initiator attachment while growth of pCBMA from Lyz-positive initiator only showed moderate further increase in activity. Growth of pSMA from both of the initiator-modified lysozyme samples rendered the conjugate inactive and the activity was completely undetectable by absorbance over the experimental time frame. This result for pSMA conjugates was not surprising, however, because strong repulsive electrostatic interactions between the large negatively charged bacteria substrate and the negatively charged pSMA coating would hinder diffusion of the substrate through the polymer to the active site. The thermal stabilities of lysozyme-initiators and subsequent lysozyme-polymer conjugates were assessed next by measuring residual activities over time during incubation at 80° C. (
Avidin: Avidin (Avi) is a tetrameric protein (homo-4-mer) that is approximately 66 kDa in its tetrameric form and is found in the egg whites of birds, reptiles, and amphibians. Its highly specific activity arises from binding strongly to biotin and this binding event is one of the strongest noncovalent interactions known, making avidin extremely useful for biochemical assays/probes and protein purification chemistries. Each sub-unit of avidin can bind to one biotin molecule. In agreement with CT and Lyz, the number of initiator modifications when using the positive initiator was less than that achieved with neutral initiator (4.3 versus 7.9). The activities of avidin samples were measured next using two different techniques (TABLE 6). Biotin binding rates were determined kinetically and total equilibrium biotin binding were determined spectophotometrically using 4′-hydroxyazobenzene-2-carboxylic acid (HABA) dye. Since the avidin-biotin binding is so strong, the displacement of HABA by biotin in the active site can be measured and the amount of bound biotin can be determined by the decrease in absorbance at 500 nm. The biotin binding rate of Avi-neutral initiator was decreased to 0.48 s−1 from 105.2 s−1 for native avidin. Avi-positive initiator, however, had a 1.7-fold increase in the biotin binding rate compared to Avi-neutral initiator. When comparing the equilibrium binding, the attachment of both neutral and positive initiators decreased the amount of biotin that was able to displace HABA, however, the binding for Avi-positive initiator was slightly increased over Avi-neutral initiator.
Uricase: In the liver, uricase catalyzes the oxidation of uric acid by gaseous molecular oxygen to produce 5-hydroxyisourate and hydrogen peroxide by the catalytic triad comprised of Thr 57, Lys 10, and His 256 (Girard et al., Biophys. J. 2010, 98(10):2365-2373; and Gabison et al., BMC Struct. Biol. 2008, 8(1):32). Uricase has a homo-tetrameric structure and the active sites of the monomers are located at dimeric interfaces. There also is a hydrophobic cavity on each monomer located next to the active site, and the flexibility of this cavity is essential for catalysis (Colloc'h and Prangé, FEBS Lett. 2014, 588(9):1715-1719). The therapeutic utility of uricase makes it an ideal target for polymer-based protein engineering, but the enzyme has been found to lose almost all activity upon polymer modification. As expected, uricase was completely inactivated upon attachment of the neutral initiator and no activity was detectable. The loss in activity was due to a combined decrease in kcat and increase in KM. Surprisingly, growth of either pCBMA or pSMA did not recover the lost activity and in fact, caused complete inactivation of uricase. Modification of uricase with the positive initiator resulted in an enzyme with detectable activity, though the activity was still significantly less than the native enzyme. The kcat value was decreased and KM was increased in comparison to native uricase, however these changes were not as significant as for Uri-neutral initiator. Growth of pCBMA from uricase-positive initiator resulted in further loss of activity, but was still detectable. Growth of pSMA however caused complete inactivation of uricase. The large decrease in activity could be due to a combination of decreased flexibility (causing decreased kcat), modification of Lys 10 in the active site (causing increased KM), and increased hydrophilicity of the cavity when using the positive initiator (causing increased KM). The thermal stabilities of uricase samples were determined next by measuring the residual activities over time at 75° C. Uri-neutral initiator stability was decreased in comparison to native uricase while Uri-positive initiator was higher than native uricase (
Acetylcholinesterase: Acetylcholinesterase (AChE) catalyzes the hydrolysis of acetylcholine to acetic acid and choline. The positively charged substrate binds to the anionic site to correctly position it for hydrolysis by the catalytic triad (Ser 200, Glu 327, His 440) (Axelsen et al., Protein Sci. 1994, 3(2):188-197; and Dvir et al., Chem. Biol. Interact. 2010, 187(1-3):10-22). AChE-initiators showed decreased activities in comparison to native AChE. AChE-neutral initiator and AChE-positive initiator had similar kcat values, but the KM for the AChE-positive initiator complex was about 2.4× higher, leading to a lower overall catalytic efficiency. A tertiary structure-based prediction of reactive amino groups was performed (Carmali et al., supra) on acetylcholinesterase (PDB: 1EEA) and Lys 325, located closely to the active site residue Glu 327, was determined to be fast-reacting. The decrease in substrate affinity of the AChE-positive initiator was therefore most likely due to modification of Lys 325, which would have disrupted the anionic nature of the substrate binding site. AChE-neutral initiator-pCBMA had further decreased activity in comparison to AChE-neutral initiator due largely to a decrease in kcat and the activity of AChE-neutral initiator-pSMA was undetectable. AChE-positive initiator-pCBMA had regained the activity lost upon attachment of the positive initiator and was the sample that had the highest activity of all of the modified AChE samples. Additionally, while the activity was undetectable for AChE-neutral initiator-pSMA, the growth of pSMA from AChE-positive initiator produced a conjugate with detectable activity. Thermal stabilities of acetylcholinesterase samples were determined next by measuring the residual activities over time at 50° C. (
Thus, in all cases, the protein-positive initiator samples examined had increased thermostability in comparison to the protein-neutral initiators. The stability curves of protein-positive initiators highly mimicked the thermostability of their native proteins, similar to the results for CT. The fact that these findings were independent of protein type further supported the idea that restoration of surface charge through engineered charged initiators can stabilize proteins through long-range electrostatic interactions.
Protein-polymer conjugate structure-function-dynamic relationships are important to understand in order to help guide future conjugate designs with optimal function. As demonstrated herein, the design of ATRP-initiators, a factor that is often overlooked in the design process, is of equal importance to polymer design. The charge of the ATRP-initiator should be similar to the charge of the targeted residue to be modified so that the protein surface charge is restored prior to ATRP.
It is to be understood that while the invention has been described in conjunction with the detailed description thereof, the foregoing description is intended to illustrate and not limit the scope of the invention, which is defined by the scope of the appended claims. Other aspects, advantages, and modifications are within the scope of the following claims.
Claims
1. A method for generating a protein-initiator conjugate, comprising contacting a protein with an controlled radical polymerization (CRP) initiator, wherein the CRP initiator comprises an amine-reactive group, one or more alkyl halide groups, and a positively charged group.
2. The method of claim 1, wherein the amine-reactive group comprises an active ester.
3. The method of claim 2, wherein the active ester comprises an N-hydroxysuccinimide ester, a nitrophenol ester, a pentafluorophenol ester, or an oxybenzotriaole ester.
4. The method of claim 1, wherein the alkyl halide comprises bromine.
5. The method of claim 1, wherein the positively charged group comprises a quaternary ammonium.
6. The method of claim 1, wherein the protein is an enzyme.
7. The method of claim 6, wherein the enzyme is an esterase, a lipase, an organophosphate hydrolase, an aminase, an oxidoreductase, a hydrogenase, or lysozyme.
8. A protein-initiator conjugate comprising a protein coupled to a CRP initiator, wherein the CRP initiator comprises an amine-reactive group, one or more alkyl halide groups, and a positively charged group.
9. The protein-initiator conjugate of claim 8, wherein the amine-reactive group comprises an active ester.
10. The protein-initiator conjugate of claim 9, wherein the active ester comprises an N-hydroxysuccinimide ester, a nitrophenol ester, a pentafluorophenol ester, or an oxybenzotriaole ester.
11. The protein-initiator conjugate of claim 8, wherein the alkyl halide comprises bromine.
12. The protein-initiator conjugate of claim 8, wherein the positively charged group comprises a quaternary ammonium.
13. The protein-initiator conjugate of claim 8, wherein the protein is an enzyme.
14. The protein-initiator conjugate of claim 13, wherein the enzyme is an esterase, a lipase, an organophosphate hydrolase, an aminase, an oxidoreductase, a hydrogenase, or lysozyme.
15. A method for generating a protein-polymer conjugate, the method comprising contacting a protein-initiator conjugate with a population of monomers in the presence of a transition metal catalyst or metal-free organic complex that can participate in a redox reaction, wherein the initiator comprises an amine-reactive group, one or more alkyl halide groups, and a positively charged group.
16. The method of claim 15, wherein the amine-reactive group comprises an active ester.
17. The method of claim 16, wherein the active ester comprises an N-hydroxysuccinimide ester, a nitrophenol ester, a pentafluorophenol ester, or an oxybenzotriaole ester.
18. The method of claim 15, wherein the alkyl halide comprises bromine.
19. The method of claim 15, wherein the positively charged group comprises a quaternary ammonium.
20. The method of claim 15, wherein the protein is an enzyme.
21. The method of claim 20, wherein the enzyme is an esterase, a lipase, an organophosphate hydrolase, an aminase, an oxidoreductase, a hydrogenase, or lysozyme.
22. The method of claim 15, wherein the monomer is selected from the group consisting of carboxybetaine methacrylate, (oligo(ethylene glycol) methacrylate), 2-dimethylaminoethyl methacrylate, sulfobetaine methacrylate, 2-(methylsulfinyl)ethyl acrylate, oligo(ethylene oxide) methyl ether methacrylate, and (hydroxyethyl)methacrylate.
Type: Application
Filed: Aug 1, 2019
Publication Date: Oct 14, 2021
Inventors: Alan J. Russell (Gibsonia, PA), Hironobu Murata (Pittsburgh, PA)
Application Number: 17/264,455
